There are currently 1048 clinical trials in Portland, Oregon looking for participants to engage in research studies. Trials are conducted at various facilities, including Oregon Health & Science University, Oregon Health and Science University /ID# 216891, Providence Portland Medical Center and Providence Saint Vincent Medical Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
SARC041: Study of Abemaciclib Versus Placebo in Patients With Advanced Dedifferentiated Liposarcoma
Recruiting
This is a Phase 3 randomized double-blind study of abemaciclib versus placebo. Patients with progression of disease will cross over to open label abemaciclib.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/11/2023
Locations: Oregon Health & Science University, Portland, Oregon
Conditions: Advanced Dedifferentiated Liposarcoma
Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping)
Recruiting
An extension of the PREMOD2 trial, the PREMOD2 Follow-Up trial will evaluate the neurodevelopmental outcomes at 22-26 months corrected age of preterm children who received UCM or DCC. This prospective multi-national randomized controlled trial (RCT) is a two-arm parallel non-inferiority design of two alternative approaches of treatment.
Gender:
All
Ages:
Between 22 months and 42 months
Trial Updated:
11/22/2022
Locations: Providence St. Vincent Medical Center, Portland, Oregon
Conditions: Neurodevelopmental Abnormality
Pediatric Cervical Spine Clearance: A Multicenter Prospective Observational Study
Recruiting
A prospective multicenter observational study, led by Dr. Katie Russell of Intermountain Primary Children's Hospital, that will examine the sensitivity, specificity, negative, and positive predictive values of CT scan and plain films in diagnosing cervical spine injury that requires treatment. This study is funded by the Primary Children's Hospital foundation.
Gender:
All
Ages:
Between 0 years and 17 years
Trial Updated:
11/01/2022
Locations: Oregon Health and Science University, Portland, Oregon
Conditions: Cervical Spine Fracture
CERENOVUS Neurothrombectomy Devices Registry
Recruiting
A post-market registry evaluating the EmboTrap® Revascularization Device and CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter in acute ischemic stroke patients with confirmed intracranial large vessel occlusion.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/19/2022
Locations: Oregon Health & Science University, Portland, Oregon
Conditions: Cerebral Stroke
Surveillance AFter Extremity Tumor surgerY
Recruiting
Following treatment for a primary extremity sarcoma, patients remain at risk for the development of local and systemic disease recurrence. Metastasis (distant recurrence) to the lung is the most frequent single location of disease recurrence in sarcoma patients, occurring in almost half of all patients. Therefore, careful post-operative surveillance is an integral element of patient care. However, the detection of metastases does not necessarily affect long-term survival and may negatively impac... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/04/2022
Locations: Oregon Health and Science University Hospital, Portland, Oregon
Conditions: Soft Tissue Sarcoma, Lung Metastases
Wearable Suicidal Early Warning System for Adolescents
Recruiting
This study is prospectively enrolling a cohort of adolescent patients who present to the Emergency Department and an inpatient psychiatric adolescent unit with acute suicidality.
Gender:
All
Ages:
Between 13 years and 19 years
Trial Updated:
09/20/2022
Locations: OHSU, Portland, Oregon
Conditions: Suicide, Adolescent Behavior
Digital Capillary Refill for Monitoring of Sepsis
Recruiting
Observational study for monitoring of capillary refill time in sepsis
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
09/20/2022
Locations: OHSU, Portland, Oregon
Conditions: Sepsis
Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations
Recruiting
This study evaluates the safety and efficacy of PTX-022 (sirolimus) Topical Gel 3.9% w/w in the treatment of Microcystic Lymphatic Malformations. The participant will receive 3 months of PTX-022 treatment by the end of the study.
Gender:
All
Ages:
13 years and above
Trial Updated:
08/26/2022
Locations: Oregon Health and Science University, Portland, Oregon
Conditions: Microcystic Lymphatic Malformation
A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita
Recruiting
This study evaluates the safety and efficacy of QTORIN 3.9% rapamycin anhydrous gel in the treatment of adults with Pachyonychia Congenita. This study includes a screening period, baseline period and 6-month treatment period.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/26/2022
Locations: Oregon Health and Sciences University, Portland, Oregon
Conditions: Pachyonychia Congenita
Comparative Effectiveness of Cryoablation Versus Steroid and Lidocaine Alone for Treatment of Morton's Neuroma
Recruiting
Morton's neuroma is a benign thickening involving the plantar interdigital nerve, most common in middle aged women. Morton's neuroma is one of the most frequent diagnoses seen in the investigators podiatry clinic and is difficult to treat. These lesions cause a burning or shooting pain that can radiate to the toes, or an aching pain in the ball of the foot. The pain is exacerbated with activity and certain footwear greatly limits activity in the involved patient population. Morton's neuroma is f... Read More
Gender:
All
Ages:
Between 18 years and 105 years
Trial Updated:
08/11/2022
Locations: Oregon Health Sciences University, Portland, Oregon
Conditions: Morton Neuroma
Sleep Duration and Cardiovascular Health
Recruiting
This is a cross-sectional study with an optional intervention that will examine how extreme sleep durations relate to cardiovascular health, physical activity, and sleep quality by studying three groups of participants: short sleepers (≤ 6 hrs), long sleepers (≥ 9 hrs), and average duration sleepers (7-8 hrs). The optional intervention asks participants to maintain an 8-hour per night regular sleep schedule for one week.
Gender:
All
Ages:
Between 25 years and 65 years
Trial Updated:
08/10/2022
Locations: Oregon Health and Science University, Portland, Oregon
Conditions: Sleep, Cardiovascular Risk Factor
Sedentary Behavior, Cardiovascular Function, and Sleep
Recruiting
This is an interventional study that will examine how sedentary behavior (decreased physical inactivity) over time affects cardiovascular health (i.e. heart rate and blood pressure) and sleep quality/duration.
Gender:
All
Ages:
Between 20 years and 80 years
Trial Updated:
08/03/2022
Locations: Oregon Institute of Occupational Health Sciences, Portland, Oregon
Conditions: Sedentary Behavior, Cardiovascular Function, Sleep